How did Twist Bioscience's Q3 2025 revenue and earnings compare to the previous quarter and year‑over‑year?
Answer
Based on the excerpt you shared, the press release announces that Twist Bioscience (NASDAQ: TWST) has posted its fiscal‑2025 third‑quarter results (quarter ended June 30 2025) and includes a quote from CEO Emily M. Leproust about the company’s balance sheet and cost‑management. However, the short summary you provided does not contain the actual revenue or earnings figures—nor the comparative numbers for the prior quarter (Q2 2025) or the same quarter in the prior year (Q3 2024).
Because the specific numbers are missing, I can’t give a precise, data‑driven comparison of:
| Metric | Q3 2025 | Q2 2025 (prior quarter) | Q3 2024 (year‑over‑year) |
|---|---|---|---|
| Revenue | ? | ? | ? |
| Earnings (Net income / Adjusted EPS) | ? | ? | ? |
What to do next
Locate the full press release – The complete earnings announcement (usually posted on the “Events and Presentations” page of Twist Bioscience’s Investor Relations site) will list:
- Total revenue for Q3 2025 and the percentage change versus Q2 2025 and Q3 2024.
- Net income (or loss) and earnings per share (EPS) for the same periods, along with the YoY and QoQ change percentages.
Check the SEC filing – The Form 10‑Q for the quarter will have the same figures in a standardized format, which can be useful if you need to cite the numbers formally.
If you have access to a financial data platform (e.g., Bloomberg, FactSet, Yahoo Finance), you can pull the quarterly results for TWST and compute the comparisons yourself:
- Quarter‑over‑quarter (QoQ) change = [(Q3 2025 – Q2 2025) / Q2 2025] × 100%
- Year‑over‑year (YoY) change = [(Q3 2025 – Q3 2024) / Q3 2024] × 100%
Contact Investor Relations – If you still can’t find the numbers, Twist Bioscience’s IR team can provide a copy of the earnings release or a fact sheet.
How the comparison is typically presented
When the numbers are available, a comprehensive answer would look like this:
- Revenue: “Twist Bioscience reported $X million in revenue for Q3 2025, representing a Y% increase over Q2 2025 and a Z% increase over Q3 2024.”
- Earnings: “Net income was $A million (or a loss of $A million), translating to B cents per share. This reflects a C% change versus Q2 2025 and a D% change versus Q3 2024.”
If the press release also includes guidance (e.g., outlook for Q4 2025 or FY 2025), that can be added to round out the analysis.
Bottom line
The current summary does not provide the quantitative data needed to answer the question directly. To deliver a fully detailed comparison, you’ll need to retrieve the complete earnings release (or the accompanying SEC filing) where Twist Bioscience lists its Q3 2025 revenue and earnings alongside the quarter‑over‑quarter and year‑over‑year changes. Once you have those figures, you can calculate and present the exact percentage differences as illustrated above. If you can share the full release or the specific numbers, I’ll be happy to craft a precise, data‑driven comparison for you.